Biotech

All Articles

Takeda touches brand-new head people oncology business-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, firings as wel...

Vertex, hammered by AATD again, falls 2 properties on throw out pile

.Vertex's attempt to manage a rare hereditary illness has struck yet another problem. The biotech sh...

Vir gains 3 T-cell engagers coming from Sanofi, gives up 25% of personnel

.Vir Medical's second-quarter revenues report had not been short of major headlines. The business ac...

Galapagos pauses CAR-T tissue therapy trial over Parkinsonism scenario

.Galapagos has actually paused registration in a trial of a BCMA-directed CAR-T cell treatment, push...

James Wilson leaving behind Penn to introduce two new biotechs

.After much more than three decades, genetics treatment innovator James Wilson M.D., Ph.D., is actua...

3 biotechs try to defeat the summer season warm by dropping staff

.As biotechs seek to switch a fresh page in August, at least three business have lost personnel in t...

venBio raises $528M for fifth lifestyle scientific researches VC fund

.Professional financial backing company venBio has actually lifted another half a billion dollars to...

Otsuka pays out $800M for Jnana and its own clinical-stage PKU medicine

.Otsuka Drug has actually gotten Boston-based Jnana Rehabs for $800 thousand so the Japanese biotech...

FibroGen gives up 75% people staff as resource fails 2 additional trials

.FibroGen is actually substantially restructuring its company, giving up 75% of its own USA team as ...

Tracon winds down full weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has determined to unwind operations full weeks after an injectable invulnera...